BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32458023)

  • 21. Estrogen-dependent gene transcription in human breast cancer cells relies upon proteasome-dependent monoubiquitination of histone H2B.
    Prenzel T; Begus-Nahrmann Y; Kramer F; Hennion M; Hsu C; Gorsler T; Hintermair C; Eick D; Kremmer E; Simons M; Beissbarth T; Johnsen SA
    Cancer Res; 2011 Sep; 71(17):5739-53. PubMed ID: 21862633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoubiquitination of Histone H2B Blocks Eviction of Histone Variant H2A.Z from Inducible Enhancers.
    Segala G; Bennesch MA; Pandey DP; Hulo N; Picard D
    Mol Cell; 2016 Oct; 64(2):334-346. PubMed ID: 27692985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of the MDM2-p53 pathway by the ubiquitin ligase HERC2.
    García-Cano J; Sánchez-Tena S; Sala-Gaston J; Figueras A; Viñals F; Bartrons R; Ventura F; Rosa JL
    Mol Oncol; 2020 Jan; 14(1):69-86. PubMed ID: 31665549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PATZ1 interacts with p53 and regulates expression of p53-target genes enhancing apoptosis or cell survival based on the cellular context.
    Valentino T; Palmieri D; Vitiello M; Pierantoni GM; Fusco A; Fedele M
    Cell Death Dis; 2013 Dec; 4(12):e963. PubMed ID: 24336083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential response between the p53 ubiquitin-protein ligases Pirh2 and MdM2 following DNA damage in human cancer cells.
    Duan W; Gao L; Wu X; Zhang Y; Otterson GA; Villalona-Calero MA
    Exp Cell Res; 2006 Oct; 312(17):3370-8. PubMed ID: 16934800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histone H2B Ubiquitylation Regulates Histone Gene Expression by Suppressing Antisense Transcription in Fission Yeast.
    Pagé V; Chen JJ; Durand-Dubief M; Grabowski D; Oya E; Sansô M; Martin RD; Hébert TE; Fisher RP; Ekwall K; Tanny JC
    Genetics; 2019 Sep; 213(1):161-172. PubMed ID: 31345994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cisplatin causes cell death via TAB1 regulation of p53/MDM2/MDMX circuitry.
    Zhu Y; Regunath K; Jacq X; Prives C
    Genes Dev; 2013 Aug; 27(16):1739-51. PubMed ID: 23934659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p21(WAF1) is component of a positive feedback loop that maintains the p53 transcriptional program.
    Pang LY; Scott M; Hayward RL; Mohammed H; Whitelaw CB; Smith GC; Hupp TR
    Cell Cycle; 2011 Mar; 10(6):932-50. PubMed ID: 21368573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. USP49-Mediated Histone H2B Deubiquitination Regulates HCT116 Cell Proliferation through MDM2-p53 Axis.
    Shi L; Shen X; Shen Y
    Mol Cell Biol; 2022 Mar; 42(3):e0043421. PubMed ID: 35072515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents.
    Mujoo K; Watanabe M; Nakamura J; Khokhar AR; Siddik ZH
    J Cancer Res Clin Oncol; 2003 Dec; 129(12):709-18. PubMed ID: 14513366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The enigmatic role of H2Bub1 in cancer.
    Johnsen SA
    FEBS Lett; 2012 Jun; 586(11):1592-601. PubMed ID: 22564770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mdmx promotes genomic instability independent of p53 and Mdm2.
    Carrillo AM; Bouska A; Arrate MP; Eischen CM
    Oncogene; 2015 Feb; 34(7):846-56. PubMed ID: 24608433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MDM2 Associates with Polycomb Repressor Complex 2 and Enhances Stemness-Promoting Chromatin Modifications Independent of p53.
    Wienken M; Dickmanns A; Nemajerova A; Kramer D; Najafova Z; Weiss M; Karpiuk O; Kassem M; Zhang Y; Lozano G; Johnsen SA; Moll UM; Zhang X; Dobbelstein M
    Mol Cell; 2016 Jan; 61(1):68-83. PubMed ID: 26748827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. let-7b and let-7c microRNAs promote histone H2B ubiquitylation and inhibit cell migration by targeting multiple components of the H2B deubiquitylation machinery.
    Spolverini A; Fuchs G; Bublik DR; Oren M
    Oncogene; 2017 Oct; 36(42):5819-5828. PubMed ID: 28604753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cisplatin in Combination with MDM2 Inhibition Downregulates Rad51 Recombinase in a Bimodal Manner to Inhibit Homologous Recombination and Augment Tumor Cell Kill.
    Xie X; He G; Siddik ZH
    Mol Pharmacol; 2020 Apr; 97(4):237-249. PubMed ID: 32063580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early Loss of Histone H2B Monoubiquitylation Alters Chromatin Accessibility and Activates Key Immune Pathways That Facilitate Progression of Ovarian Cancer.
    Hooda J; Novak M; Salomon MP; Matsuba C; Ramos RI; MacDuffie E; Song M; Hirsch MS; Lester J; Parkash V; Karlan BY; Oren M; Hoon DS; Drapkin R
    Cancer Res; 2019 Feb; 79(4):760-772. PubMed ID: 30563893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DDB2 decides cell fate following DNA damage.
    Stoyanova T; Roy N; Kopanja D; Bagchi S; Raychaudhuri P
    Proc Natl Acad Sci U S A; 2009 Jun; 106(26):10690-5. PubMed ID: 19541625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7.
    Bao-Lei T; Zhu-Zhong M; Yi S; Jun-Jie Q; Yan D; Hua L; Bin L; Guo-Wei Z; Zhi-Xian S
    J Cell Biochem; 2006 Feb; 97(3):561-71. PubMed ID: 16215989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FKBP25, a novel regulator of the p53 pathway, induces the degradation of MDM2 and activation of p53.
    Ochocka AM; Kampanis P; Nicol S; Allende-Vega N; Cox M; Marcar L; Milne D; Fuller-Pace F; Meek D
    FEBS Lett; 2009 Feb; 583(4):621-6. PubMed ID: 19166840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myeloid progenitor cells lacking p53 exhibit delayed up-regulation of Puma and prolonged survival after cytokine deprivation.
    Jabbour AM; Daunt CP; Green BD; Vogel S; Gordon L; Lee RS; Silke N; Pearson RB; Vandenberg CJ; Kelly PN; Nutt SL; Strasser A; Borner C; Ekert PG
    Blood; 2010 Jan; 115(2):344-52. PubMed ID: 19965665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.